Thomas E. Witzig

410 total citations
4 papers, 315 citations indexed

About

Thomas E. Witzig is a scholar working on Hematology, Surgery and Molecular Biology. According to data from OpenAlex, Thomas E. Witzig has authored 4 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Hematology, 1 paper in Surgery and 1 paper in Molecular Biology. Recurrent topics in Thomas E. Witzig's work include Blood Coagulation and Thrombosis Mechanisms (2 papers), Acute Myeloid Leukemia Research (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). Thomas E. Witzig is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (2 papers), Acute Myeloid Leukemia Research (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). Thomas E. Witzig collaborates with scholars based in United States and Switzerland. Thomas E. Witzig's co-authors include Robert A. Kyle, W. Michael O’Fallon, Richard E. Bélanger, Magnus Dahlbom, Andrew Raubitschek, Kastytis C. Karvelis, Christine A. White, Michael Stabin, William D. Erwin and Timothy E. Schultheiss and has published in prestigious journals such as British Journal of Haematology, European Journal of Nuclear Medicine and Molecular Imaging and American Journal of Hematology.

In The Last Decade

Thomas E. Witzig

4 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas E. Witzig United States	4	156	99	93	83	81	4	315
Michael Tomblyn United States	9	202 1.3×	34 0.3×	57 0.6×	103 1.2×	33 0.4×	20	399
S. von Harsdorf Germany	3	83 0.5×	39 0.4×	103 1.1×	50 0.6×	33 0.4×	5	243
Mary McCauley United States	7	29 0.2×	59 0.6×	46 0.5×	129 1.6×	60 0.7×	13	306
M Harrison United States	7	224 1.4×	36 0.4×	92 1.0×	199 2.4×	22 0.3×	9	488
Jean-François Rosier Belgium	11	60 0.4×	20 0.2×	19 0.2×	149 1.8×	89 1.1×	14	389
Erica Finolezzi Italy	10	33 0.2×	210 2.1×	106 1.1×	103 1.2×	111 1.4×	22	433
Alicia Marín Spain	8	99 0.6×	14 0.1×	47 0.5×	76 0.9×	42 0.5×	15	311
D. Gilson United Kingdom	10	67 0.4×	93 0.9×	8 0.1×	86 1.0×	27 0.3×	21	292
Kathryn Fife United Kingdom	8	23 0.1×	65 0.7×	57 0.6×	108 1.3×	54 0.7×	12	283
M. Bamberg Germany	6	60 0.4×	14 0.1×	36 0.4×	134 1.6×	48 0.6×	11	345

Countries citing papers authored by Thomas E. Witzig

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Witzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Witzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Witzig more than expected).

Fields of papers citing papers by Thomas E. Witzig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Witzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Witzig. The network helps show where Thomas E. Witzig may publish in the future.

Co-authorship network of co-authors of Thomas E. Witzig

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Witzig. A scholar is included among the top collaborators of Thomas E. Witzig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Witzig. Thomas E. Witzig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Wiseman, Gregory A., Christine A. White, Michael Stabin, et al.. (2000). Phase I/II 90 Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma. European Journal of Nuclear Medicine and Molecular Imaging. 27(7). 766–777. 189 indexed citations

2.

Alberts, Steven R., et al.. (1999). Thrombosis Related to the Use of L-Asparaginase in Adults with Acute Lymphoblastic Leukemia: a Need to Consider Coagulation Monitoring and Clotting Factor Replacement. Leukemia & lymphoma. 32(5-6). 489–496. 20 indexed citations

3.

Gertz, Morie A., et al.. (1999). Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis. American Journal of Hematology. 61(2). 115–119. 31 indexed citations

4.

Witzig, Thomas E., et al.. (1994). Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma. British Journal of Haematology. 87(2). 266–272. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact